First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...
A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a ...
Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...
Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says ...
Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...
The repayment satisfies the Company’s obligations under the Loan and Security Agreement originally entered into on October 29, 2021, with BroadOak Fund V, L.P. By retiring this debt early, Interpace ...
The entry-level pad controller offers a slick, simplified workflow for Serato Studio, but can also work with Serato Sample ...
The One Big Beautiful Bill Act (the “Act”) includes significant amendments to bonus depreciation under Section 168(k). The Act permanently ...
Enhancing Ireland’s Competitiveness: The Action Plan’s focus on streamlining planning, regulatory, and legal processes will ...
This was not the first presentation on STI-571, but it was the one that would change everything: The New England Journal of ...
News-Medical.Net on MSN
Human researchers still outperform AI when it comes to writing trustworthy systematic reviews
Human researchers outperformed large language models across all major stages of systematic review preparation, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback